We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+12.03%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+601.59%
AUM
$1.04T
AUM Growth
+$136B
Cap. Flow
+$33.3B
Cap. Flow %
3.19%
Top 10 Hldgs %
19.7%
Holding
8,129
New
701
Increased
3,666
Reduced
2,249
Closed
619

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Healthcare 9.65%
3 Financials 9.27%
4 Consumer Discretionary 8.86%
5 Industrials 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TARA icon
7026
Protara Therapeutics
TARA
$233M
$30 ﹤0.01%
16
+5
+45% +$7
FSI icon
7027
Flexible Solutions
FSI
$63.7M
$29 ﹤0.01%
15
+5
+50% +$10
RPTX
7028
DELISTED
Repare Therapeutics
RPTX
$29 ﹤0.01%
4
-8,147
-100% -$45.6K
RVP icon
7029
Retractable Technologies
RVP
$20.3M
$29 ﹤0.01%
26
+10
+63% +$11
SRZN icon
7030
Surrozen
SRZN
$279M
$29 ﹤0.01%
3
+1
+50% +$7
CYTH
7031
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$29 ﹤0.01%
18
-222
-93% -$283
AFK icon
7032
VanEck Africa Index ETF
AFK
$104M
$28 ﹤0.01%
2
ELUT icon
7033
Elutia
ELUT
$38M
$28 ﹤0.01%
13
-3,689
-100% -$6.05K
RMCF icon
7034
Rocky Mountain Chocolate Factory
RMCF
$15.6M
$28 ﹤0.01%
6
+1
+20% +$4
SNTI icon
7035
Senti Biosciences Holdings
SNTI
$12M
$28 ﹤0.01%
4
+1
+33% +$4
VIP
7036
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$33.5M
$27 ﹤0.01%
4
+3
+300% +$15
UPXI icon
7037
Upexi
UPXI
$54.8M
$27 ﹤0.01%
1
TRAW icon
7038
Traws Pharma
TRAW
$9.14M
$27 ﹤0.01%
1
ORKA
7039
Oruka Therapeutics
ORKA
$7.16B
$27 ﹤0.01%
1
MVLA
7040
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$27 ﹤0.01%
+44
New +$20
BDL icon
7041
Flanigan's Enterprises
BDL
$89.2M
$26 ﹤0.01%
1
CKX icon
7042
CKX Lands
CKX
$21.8M
$26 ﹤0.01%
2
CNTX icon
7043
Context Therapeutics
CNTX
$46.5M
$26 ﹤0.01%
23
+7
+44% +$8
CREX icon
7044
Creative Realities
CREX
$44M
$26 ﹤0.01%
11
+4
+57% +$8
DUOT icon
7045
Duos Technologies
DUOT
$294M
$26 ﹤0.01%
9
+3
+50% +$11
KINS icon
7046
Kingstone Companies
KINS
$282M
$26 ﹤0.01%
12
+2
+20% +$4
PMCB icon
7047
PharmaCyte Biotech
PMCB
$5.9M
$26 ﹤0.01%
12
-5
-29% -$11
SANW
7048
DELISTED
S&W Seed Co
SANW
$26 ﹤0.01%
2
+1
+100% +$13
BIOR
7049
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$26 ﹤0.01%
2
+1
+100% +$16
ASTC icon
7050
Astrotech Corp
ASTC
$17.9M
$25 ﹤0.01%
3
+1
+50% +$9

Similar funds

JP Morgan Chase's Q4 2023 Portfolio in Review

As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

JP Morgan Chase deployed $33.3B of net new capital in Q4 2023, opening 701 new positions and adding to 3,666 existing holdings. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $3.18B trimmed.

  • JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
  • JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
  • JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
  • JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
  • JP Morgan Chase opened 701 new positions and closed 619 in Q4 2023.
  • JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.

Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.